Why Shares of Zai Lab Are Dropping Wednesday

The company released a phase 3 trial regarding a non-small cell lung cancer therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.